Included In This Lesson
Outline
What is the generic name?
GLASDEGIB
What is the Trade Name for GLASDEGIB?
Daurismo
What are the Indications for GLASDEGIB?
- 1 INDICATIONS AND USAGE DAURISMO is indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are ≥75 years old or who have comorbidities that preclude use of intensive induction chemotherapy. DAURISMO is a hedgehog pathway inhibitor indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are ≥75 years old or who have comorbidities that preclude use of intensive induction chemotherapy. ( 1 )
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources